Abstract Many studies are uncovering functional roles for long noncoding RNAs (lncRNAs), yet few have been tested for in vivo relevance through genetic ablation in animal models. To investigate the functional relevance of lncRNAs in various physiological conditions, we have developed a collection of 18 lncRNA knockout strains in which the locus is maintained transcriptionally active. Initial characterization revealed peri-and postnatal lethal phenotypes in three mutant strains (Fendrr, Peril, and Mdgt), the latter two exhibiting incomplete penetrance and growth defects in survivors. We also report growth defects for two additional mutant strains . Further analysis revealed defects in lung, gastrointestinal tract, and heart in Fendrr −/− neonates, whereas linc-Brn1b −/− mutants displayed distinct abnormalities in the generation of upper layer II-IV neurons in the neocortex. This study demonstrates that lncRNAs play critical roles in vivo and provides a framework and impetus for future larger-scale functional investigation into the roles of lncRNA molecules.
Introduction
Mammalian genomes encode thousands of long noncoding RNAs (lncRNAs), which are emerging as key regulators of cellular processes (Rinn and Chang, 2012; Mercer and Mattick, 2013) . Gain-and loss-of-function approaches in cell-based in vitro systems have been useful in uncovering important roles for lncRNAs, such as modulating chromatin states, maintaining cellular identity (i.e. pluripotency) and regulating cell cycle and translation (Tsai et al., 2010; Guttman et al., 2011; Wang et al., 2011; Yoon et al., 2012) . Genome-wide association and expression profiling studies in humans have also identified correlations between lncRNA mutation, misregulation and disease states (Visel et al., 2010; Cabili et al., 2011; Brunner et al., 2012 ). Yet, direct in vivo, genetic evidence of the functional significance of lncRNAs as a class of transcripts remains elusive.
Functional studies in knockout mouse models have provided compelling evidence for the requirement and sufficiency of particular transcripts for organ development and function. However, small and large-scale efforts have focused primarily on protein coding genes, leaving long noncoding RNAs vastly understudied (Edwards et al., 2011; White et al., 2013) . Of the few lncRNA mutant mice generated to date, most involved previously studied and classic examples of lncRNAs (e.g., Xist, H19, Kcn11ot1, Malat1) (Anguera et al., 2011; Gomez et al., 2013; Gordon et al., 2010; Moseley et al., 2006; Nakagawa et al., 2011; Ripoche et al., 1997; Zhang et al., 2012) , leaving the more recent large-scale RNA-Seq-derived catalogs of lincRNAs largely unexplored. The progress made in these early studies to initiate functional characterization of lncRNAs in vivo now warrants a larger investigation of their biological importance to development and disease.
To address this directly, and to begin to explore the roles of lncRNAs in vivo, we have established a novel cohort of lncRNA knockout mice. We focused on a subgroup of lncRNAs called long intergenic noncoding RNAs (lincRNAs), such that genetic deletion would not overlap known protein coding genes or other known gene annotations. We have implemented a generalized and logical lincRNA candidate selection process that leverages a collection of cell-based functional assays, RNA-sequencing data and computational analyses. This approach led us to identify 18 lincRNAs for targeted deletion in mouse. Initial characterization of these new knockout strains demonstrated key functional roles in viability, development of the cerebral cortex and other developmental processes. In this study, we describe the observed phenotypes for five strains within this collection. Collectively, these data provide evidence that lincRNAs play central roles in mammalian development and physiology.
Results

Global characterization of lincRNA knockout candidate selection
To more globally understand the physiological significance of lincRNAs, we combined a step-wise lincRNA selection pipeline with a genetic approach to engineer a cohort of lincRNA knockout mouse strains for functional analysis. We integrated several computational and experimental data sets to select bona fide lincRNA candidates across three lincRNA catalogs UCSC and Refseq) . First, all transcripts with identifiable Pfam domains or those overlapping known non-lncRNA annotations (e.g., annotated protein coding genes, microRNAs, tRNAs and pseudogenes) were excluded. Second, we excluded any remaining transcripts with conserved protein coding potential, including eLife digest The mammalian genome is comprised of DNA sequences that contain the templates for proteins, and other DNA sequences that do not code for proteins. The coding DNA sequences are transcribed to make messenger RNA molecules, which are then translated to make proteins. Researchers have known for many years that some of the noncoding DNA sequences are also transcribed to make other types of RNA molecules, such as transfer and ribosomal RNA. However, the true breadth and diversity of the roles played by these other RNA molecules have only recently begun to be fully appreciated.
Mammalian genomes contain thousands of noncoding DNA sequences that are transcribed. Recent in vitro studies suggest that the resulting long noncoding RNA molecules can act as regulators of transcription, translation, and cell cycle. In vitro studies also suggest that these long noncoding RNA molecules may play a role in mammalian development and disease. Yet few in vivo studies have been performed to support or confirm such hypotheses. Now Sauvageau et al. have developed several lines of knockout mice to investigate a subset of noncoding RNA molecules known as long intergenic noncoding RNAs (lincRNAs). These experiments reveal that lincRNAs have a strong influence on the overall viability of mice, and also on a number of developmental processes, including the development of lungs and the cerebral cortex.
Given that the vast majority of the human genome is transcribed, the mouse models developed by Sauvageau et al. represent an important step in determining the physiological relevance, on a genetic level, of the noncoding portion of the genome in vivo. DOI: 10.7554/eLife.01749.002 the potential to produce small peptides, by performing stringent codon-substitution frequency (CSF) analysis (Lin et al., 2011) . We previously demonstrated that this algorithm is capable of discriminating known functional small peptides down to 11 amino acids (Guttman and Rinn, 2012; Guttman et al., 2013) . Using selective criteria, we restricted candidate lincRNAs to those with CSF scores <−200 (ranging from −205 to −14,771, Figure 1A ). Then, we examined existing ribosome profiling datasets to quantitate the ability of these transcripts to engage the ribosome (Figure 1-figure supplement 1 ). None of the tested candidates were shown to have clear translation efficiency or codon bias according to proposed standards (Guttman et al., 2013) . Finally, through genome lift-over of our mouse lincRNAs to the human genome (build hg19), we examined mass spectrometry data by Gascoigne et al. (2012) to discard transcripts with mapped peptides. We kept transcripts with only two or less mass spectrometry tags, consistent with low levels of background ribosome association observed by Guttman et al. (2013) (Supplementary file 1B) . Thus, based on an exhaustive analysis of existing annotations, standard evolutionary and ribosome profiling metrics, as well as mass spectrometry data, these candidates do not appear to contain protein coding potential.
From this stringent list of lincRNAs, we selected 18 candidates by further considering additional criteria: (1) Presence of an observed orthologous human lincRNA with syntenic conservation as determined by TransMap (Zhu et al., 2007) ; (2) Presence of canonical chromatin features of actively transcribed genes such as histone H3 lysine 4 trimethylation (H3K4me3) at the promoter and histone H3 lysine 36 trimethylation throughout the gene body (Guttman et al., , 2010 ; (3) Local 'enhancer-like' signatures based on published P300, RNA polymerase II, histone lysine 4 monomethylation (H3K4me1) and histone lysine 27 acetylation (H3K27ac) chromatin states (Shen et al., 2012) . We selected 6/18 candidates lncRNA loci that have putative 'enhancer' modifications, thus allowing to investigate the newfound roles of lncRNAs in 'enhancer' activity (Ørom et al., 2010; Wang et al., 2011) . Collectively, this step-wise selection process resulted in 18 high-quality candidate lincRNAs with diverse features, for targeted deletion and phenotypic characterization ( Figure 1A , Supplementary file 1A for coordinates and nomenclature details).
We first examined the gene-expression patterns of the candidate lincRNAs using RNA-sequencing of various adult tissues and cell types. Several lincRNAs presented more restricted patterns of expression, suggesting strong tissue specificity, for example Celr in embryonic stem (ES)-derived neural stem cells (NSCs), linc-Enc1 in mouse ES cells, Manr and linc-Cox2 in lung, whereas a select few showed more ubiquitous expression across tissues (linc-Pint, Spasm, linc-Ppara, Tug1) ( Figure 1B) . Most of the candidate lincRNAs (12/18) were expressed in the adult brain or in ES-derived NSCs ( Figure 1B) .
Since most candidate lincRNAs in this screen have unknown biological roles, we leveraged our RNA-sequencing data using guilt-by-association (GBA) analysis to generate hypotheses on functional significance by comparing the expression of each lincRNAs to protein coding genes of known function ('Materials and methods') ( Figure 1C ). GBA predicted lincRNA activities across a wide range of pathways and biological processes, ranging from regulation of the cell cycle and chromosome organization and maintenance, to neuronal differentiation and immune response ( Figure 1C) . Overall, these analyses suggested diverse potential roles for our candidate lincRNAs.
Genetic analysis of lincRNA knockout mice reveals key roles in mammalian development
To study the function of the selected 18 lincRNAs in vivo and to resolve, at the cellular level, their expression pattern in different organs, we generated knockout mouse strains for each candidate by replacing the lincRNA gene with a lacZ reporter cassette ('Materials and methods', Figure 1-figure supplement 2 for details) (Valenzuela et al., 2003) . These new strains, which are the first lincRNA knockout models to incorporate a reporter, more than double the number of models available for investigation and constitute an important resource that will be used to better understand the functional contribution of lincRNAs to mammalian biology.
To assess the requirement for each lincRNA in embryonic development and viability, we examined the progeny from heterozygote intercrosses for all 18 strains. Genotyping of weanlings (21 days old) revealed normal Mendelian segregation of mutant alleles in 15 of the 18 strains ( Figure 1D ). For the three remaining strains Peril, Mdgt and Fendrr, the progeny of heterozygote intercrosses contained much lower numbers of homozygote mutants than expected. Only 13 Peril −/− mice (of an expected 32), and 6 Mdgt −/− mice (of an expected 17) were found at weaning age, indicating that deletion of Peril and Mdgt leads to reduced viability with >50% and 65% penetrance, respectively ( Figure 1D ). Closer examination of Mdgt pups revealed that homozygous mutants died within 2 weeks after birth. For Fendrr, no homozygous mutants were found at weaning age ( Figure 1D ), indicating that the lethal phenotype for this strain is fully penetrant. Thus, 3 out of the 18 (17%) lincRNA knockout strains generated have a lethal phenotype, confirming that specific lincRNA genes are required for viability.
Peril
−/− mice have reduced viability and die shortly after birth
To determine the onset of Peril −/− mice lethality, we monitored survival at both early and late stages of embryonic development. Since normal Mendelian ratios were observed up to E18.5 (Figure 2A) , and pups Research article appeared macroscopically normal at birth ( Figure 2B ), we monitored newborns to see if lethality occurred perinatally. We observed that 50% (5/10) of Peril −/− pups died within 2-20 days after birth ( Figure 2A) . A similar percentage (52%, 11/21) of newborn deaths occurred in the progeny of intercrosses from surviving Peril −/− mice ( Figure 2A , lower panel). These results confirmed the reduced viability of Peril mutants (∼50% penetrance) with pups dying early after birth.
Peril is a seven exon transcript derived from a 18.2 Kb genomic locus located ∼110 Kb downstream of the pluripotency factor Sox2 ( Figure 2C ). Using mouse ES cell (mES) cDNA, we were able to clone two distinct isoforms (1,831 bp and 631 bp) ( Figure 2C ). RNAseq expression profiling from a panel of mouse tissues and cell lines showed that Peril was highly enriched in mouse ES cells, but also expressed at lower levels in adult brain and testes ( Figure 2D ). The Peril transcript is predominantly nuclear as revealed by RNA fluorescence in situ hybridization (FISH) in mouse ES cells ( Figure 2E ). Using the knocked-in lacZ reporter in heterozygote embryos, tight temporal and spatial regulation of Peril was found in the brain and spinal cord of E14.5 and E18.5 embryos ( Figure 2F, Figure 2-figure supplement 1A) .
To identify putative pathways affected by deletion of Peril, we performed RNA-sequencing on E18.5 brains from Peril −/− and wild-type littermates (n = 2). Analysis of Peril expression levels confirmed the deletion of Peril ( Figure 2G) . Expression of the pluripotency factor Sox2 and its overlapping noncoding RNA Sox2ot were not significantly affected in the knockout brains ( Figure 2G ). Differentially regulated genes and gene set enrichment analysis (GSEA) revealed downregulation of genes involved in cell cycle regulation, energy metabolism, immune response, and mRNA and protein processing in Peril −/− brains relative to wild-type controls . This indicates that the transcriptional programs within the brain are in fact affected by deletion of Peril. Yet, it remains unclear if these changes underlie the observed lethality.
Fendrr
−/− is perinatal lethal due to defects in multiple organs
Fendrr is a 2,380 bp transcript consisting of six exons. It is transcribed from a bidirectional promoter shared with the protein coding gene Foxf1a, located 1,354 bp from its transcriptional start site ( Figure 3A ). An orthologous human FENDRR (LINC-FOXF1) transcript expressed from a syntenic region was identified within our catalog of human lincRNAs (Cabili et al., 2011) . We previously demonstrated that this lincRNA is predominantly nuclear and physically associates with the PRC2 Polycomb complex (Khalil et al., 2009) .
To determine the onset of Fendrr lethality, we monitored the survival of embryos at both early and late stages of embryonic development, as well as that of newborn pups. Normal Mendelian ratios were found at both E14.5 and E18.5 ( Figure 3B) , with embryos appearing macroscopically normal prior to birth ( Figure 3C) , suggesting that the lethality most likely occurred after birth. Importantly, we observed 8 Fendrr −/− mutant newborns (P0) ( Figure 3B ), all of which died within 24 hr, indicating perinatal lethality.
During the course of our study, another group generated a Fendrr loss-of-function mouse model by replacing the first exon with multiple transcriptional termination sequences (Grote et al., 2013) . In contrast to the results presented here, Grote et al. observed lethality at E13.75 due to heart and body wall (omphalocele) defects. When analyzing E14.5 embryos, we found no resorbed embryos or omphalocele in our Fendrr homozygous mutants (Figure 3-figure supplement 1) . Although, both studies used similar genetic background strains, a possible explanation for this discrepancy may be found in the distinct targeting strategy used to remove the Fendrr gene. Regardless, both studies confirm that loss of Fendrr is lethal in mice.
Grote et al. observed Fendrr expression to be restricted to nascent lateral plate mesoderm and did not detect it in any other tissue. Using RNA-Seq expression profiling from adult mouse tissues and cell lines, we however found that Fendrr is expressed at high levels in the adult lung, and lower levels are detectable in colon, liver, spleen and brain ( Figure 3D) . Analysis of the knocked-in lacZ reporter in E14.5 and E18.5 embryos confirmed expression of Fendrr in these tissues as well as in the trachea and all along the gastrointestinal tract ( Figure 3E,F) . Interestingly, in the developing respiratory and digestive tracts at E14.5 and E18.5, expression of Fendrr is restricted to the pulmonary mesenchyme surrounding the bronchiolar epithelial cells ( Figure 3E , right panels); in mesenchymal cells of the developing mucosa; the muscularis externa of the gut and in lymphoid aggregations within the gut's mucosa ( Figure 3F , bottom panel), all of which are derived from the lateral plate mesoderm.
Perinatal lethality is often associated with respiratory failure. Since the highest expression levels of Fendrr are found in the lungs, we evaluated initiation of breathing in surgically delivered E18.5 embryos. After cleaning of their airways, all Fendrr −/− embryos analyzed either failed to breathe or gasped and stopped breathing within 5 hr (n = 7 Fendrr −/− , Figure 3G ). In contrast, respiration initiated normally and was maintained for all but one of the heterozygote and wild-type embryos (n = 15 Fendrr +/− and n = 8 wild type). Fendrr −/− lungs at the pseudoglandular stage (E14.5) were hypoplastic compared to wild type ( Figure 3H ), and histological evaluation of the lungs revealed a decrease in the number and organization of pulmonary arteries, and a general failure of vasculogenesis within the lungs of the Fendrr −/− mutants compared to wild type (n = 3 Fendrr −/− and n = 3 wild type; Figure 3I , upper panels). At E18.5, Fendrr −/− lungs appeared to have fewer but larger alveoli (n = 3 Fendrr −/− and n = 3 wild type; Figure 3I , lower panels). Together, these results suggest that respiratory failure observed at birth in Fendrr −/− mice could be due to a lung maturation and vascularization defect. We also observed expression of Fendrr in the esophagus and gut. We observed thinning of the mesenchymal layer of the mucosa and external smooth muscle layers in the esophagus at E18.5 (n = 3 Fendrr −/− and n = 3 wild type; Figure 3J ). Although we did not observe Fendrr expression in the heart at E14.5, E18.5, or postnatally, we did observe intraventricular septal heart defects prior to birth (E18.5) (n = 3 Fendrr −/− and n = 3 wild type; Figure 3K ). In accordance with Fendrr having a previously described role in lateral plate mesoderm (Grote et al., 2013) , our results suggest a more general role for Fendrr in regulating the proper differentiation of mesenchyme-derived tissues across several organ systems.
We next investigated if neighboring gene expression is perturbed by the deletion of Fendrr. We harvested lungs from E14.5 Fendrr −/− embryos and wild-type littermates (n = 2) and performed differential RNA-Seq analyses. A loss of Fendrr expression in knockout relative to wild-type lungs confirmed deletion of Fendrr ( Figure 3L ). No significant change in the expression of the Foxf1a protein coding gene was observed in the Fendrr −/− lung. Furthermore, genes within ±1 Mb of the Fendrr locus were not significantly differentially expressed any more than background levels of local enrichment (Figure 3 figure supplement 2A, p<0.087; bootstrapped from random 2 Mb genomic intervals), suggesting that the Fendrr gene does not act as a local enhancer. GSEA identified gene sets involved in muscle differentiation and contraction as the most significant sets misregulated in Fendrr −/− lungs compared to wild type ( Figure 3M ). This agrees with our identification of defects in the lung vasculature of the Fendrr −/− mice. Further studies will be needed to understand how specific changes in gene-expression patterns upon deletion of Fendrr contribute to the observed defects and perinatal lethality.
Ablation of distinct lincRNA genes affects mouse growth
To determine if deletion of our candidate lincRNAs affects normal development and growth postnatally, each strain was examined for gross morphological abnormalities and body weight (BW) measurements were taken. Homozygote mutant mice with heterozygote and wild-type littermate controls were compared over a 7-10 week period. Mdgt −/− pups displayed a severe growth retardation phenotype, which may contribute to their lethality (Figure 4C, D) . A week after birth, Mdgt −/− pups were already significantly smaller than heterozygote and wild-type littermates ( Figure 4C ), with females 60% smaller (n = 5, p<0.00001) than wild-type littermates (n = 10) and males 32% smaller (n = 3, p<0.05), suggesting a sex bias in this phenotype. In Mdgt −/− survivors, this retarded growth persisted up to 10 weeks in females, which were still 37% smaller than wild types ( Figure 4D , p<0.0006). The defect, although milder, also persisted in male mutants up to at least 8 weeks.
Mdgt is a 443 bp transcript consisting of three exons transcribed from a bidirectional promoter shared with the homeobox gene Hoxd1. The first exon for Mdgt is located only 84 bp away from the Hoxd1 transcription start site. Another noncoding transcript, AK144266, is contained within an intron of Mdgt and appears to be expressed from the opposite strand ( Figure 4A ). In our targeting strategy, the entire Mdgt locus was deleted, including the AK144266 transcript ( Figure 4A ). Expression estimates obtained from RNA-Seq revealed that Mdgt is highly expressed in testes, and more moderately in brain, kidney, colon and skeletal muscles ( Figure 4B) . lacZ staining confirmed expression in those tissues and also revealed expression in stomach and thymus ( Figure 4E ).
In addition to Mdgt, stunted growth defects were also observed in three other strains (Figure 4-figure supplement 1) . 3 weeks after birth, linc-Pint −/− mice were noticeably smaller than wild-type littermates (Figure 4-figure supplement 1A) . By 7 weeks of age, females had 22% reduced body weight (n = 5, p<0.001) compared to wild type (n = 4), whereas males were 29% smaller (n = 3 linc-Pint −/− ; n = 3 wild type, p<0.05). A decrease in body weight was also observed by three weeks of age in linc-Brn1b −/− (29%, p<0.013, n = 3) and Peril −/− mice (35%, p<0.0003, n = 4) when compared to wild-type littermates (n = 3) (Figure 4-figure supplement 1B,C) . Together, these results indicate that specific lincRNAs can be important for normal body weight and growth.
Identification of developmentally regulated human lincRNA orthologs
In order to determine whether loss of our candidate lincRNAs could lead to other developmental defects, we examined additional mutant strains that did not show perinatal lethality. Building on prior evidence that lincRNAs are abundantly expressed and spatio-temporally regulated within the brain during development and adulthood (Mercer et al., 2008; Qureshi et al., 2010; Cabili et al., 2011; Ramos et al., 2013) , we concentrated on the candidate lincRNAs that were expressed in the brain or in neural progenitors. Twelve of the lincRNAs for which we have established knockout strains exhibited such expression profile ( Figure 1B) . To focus on lincRNA candidates of potential functional relevance in neuronal development, we used syntenic orthology (TransMap [Zhu et al., 2007] ) and RNA-sequencing to select those with identifiable human orthologs, and whose expression was regulated during in vitro neural differentiation.
Briefly, transcripts expressed along a time course of ES-derived human neural stem cells (NSC) differentiation (Goff et al., 2009) (Figure 5A ) were assembled and aggregated with an existing compendium of RNA-Seq data, using our previously described lincRNA discovery pipeline (Cabili et al., 2011) .
The resulting lincRNA catalog contained 24,737 distinct, high-quality transcript reconstructions corresponding to 14,259 human lincRNA genes. We observed 769 lincRNA genes with significant differential expression (q<0.01; Cuffdiff2) between any two adjacent time points during NSC differentiation. With a false discovery rate of 1% ( Figure 5-figure supplement 1) , 302 of these were significantly induced relative to day 0 ( Figure 5-figure supplement 1 ). This approach revealed that 7 lincRNAs from our mouse knockout strains have human orthologs that are dynamically induced during in vitro human neuronal differentiation ( Figure 5B) . Interestingly, two of these, linc-Brn1a and linc-Brn1b, were almost exclusively expressed in NSCs as determined by RNA-Seq ( Figure 1B) . These lincRNAs reside in the genomic region of Brn1 (Pou3f3), a well-studied transcription factor involved in cortical development (McEvilly, 2002; Sugitani et al., 2002; Dominguez et al., 2012) . We thus focused on this locus, starting with linc-Brn1b, as it is not transcribed from a bidirectional promoter and therefore deletion does not disrupt the Brn1 promoter.
Linc-Brn1b expression is spatio-temporally restricted in the developing cerebral cortex
Using RNA-Seq data, we observed linc-Brn1b to be predominantly expressed in ES-derived NSCs with additional moderate expression in the adult brain and kidney ( Figure 5C ). The linc-Brn1b gene is a ∼3 Kb transcript derived from a 6.8 Kb genomic locus approximately 10 Kb downstream of the Brn1 protein coding gene. To generate the linc-Brn1b knockout mice, we targeted the entire linc-Brn1b locus ( Figure 5D ). Complete ablation was confirmed by qRT-PCR ( Figure 5E ) using adult brain cDNA as template. RNA-FISH in mouse E14.5 neural progenitor cells (NPCs) isolated from the cerebral cortex demonstrated that the linc-Brn1b transcript is predominantly nuclear with moderate cytoplasmic expression ( Figure 5F ).
While identified as a lincRNA expressed in adult brain, the spatio-temporal distribution of linc-Brn1b during brain development is not known. Therefore, we used lacZ expression from the linc-Brn1b locus in heterozygote mutants to define its expression in vivo. We found that linc-Brn1b was expressed within neural progenitors of both the ventral and dorsal telencephalon, as early as E13.5 ( Figure 5G ). −/− cortex shows linc-Brn1b expression in layer IV of the somatosensory area (white boxes), specifically within the barrel structures (white arrows), as determined by co-staining with the upper layer markers SATB2 and CUX1. Abbreviations: LV, lateral ventricle; LGE, lateral ganglionic eminence; MGE, medial ganglionic eminence; CGE, caudal ganglionic eminence; CP, cortical plate; SVZ, subventricular zone; VZ, ventricular zone; Str, striatum; M1, primary motor area; S1, primary somatosensory area; cc, corpus callosum; V1, primary visual cortex; A1, primary auditory cortex; F/M, frontal motor cortex. Scale bars: 500 µm (G), (I, upper panels); 100 µm (I, lower panels). DOI: 10.7554/eLife.01749.013 The following figure supplements are available for figure 5: 
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Detailed characterization of expression in the germinal zones of the dorsal telencephalon showed that by E15.5, it was strongly expressed in progenitors of both the ventricular zone (VZ) and the subventricular zone (SVZ) of the developing cerebral cortex, and by E18.5 showed restricted expression in the developing upper cortical layers. In addition, whole-mount lacZ staining at P7, showed a specific areal distribution for linc-Brn1b within both the primary somatosensory cortex and the primary visual cortex ( Figure 5H ). Within the somatosensory cortex, linc-Brn1b was expressed in the barrel structures of the posteromedial barrel subfield (PMBSF) ( Figure 5I) ; a highly organized region of cortical projection neurons that receives afferent connections from the thalamus and is responsible for the coordination of sensory inputs from the rodent vibrissae (Petersen, 2007) .
Collectively, the timing and location of linc-Brn1b expression within the developing cortex suggests a potential role for linc-Brn1b in area-specific development of distinct classes of projection neurons.
Loss of linc-Brn1b results in specific reduction in the number of intermediate progenitor cells (IPCs) in the cerebral cortex
To investigate the consequences of genetic deletion of linc-Brn1b during development of the telencephalon, we performed RNA-Seq on E13.5 and E15.5 whole telencephalons and P7 whole brains (n = 2) of wild type and linc-Brn1b −/− mice. At all time points, RNA-Seq analyses identified a statistically significant reduction (∼50%) in expression of the neighboring Brn1 protein coding gene in linc-Brn1b −/− brains relative to wild type (E15.5 shown in Figure 6A , Figure 6 -figure supplement 1A,B). We observed a similar decrease in BRN1 protein expression between wild type and linc-Brn1b −/− E14.5 cortical-derived neurospheres and E15.5 whole cortex samples ( Figure 6B ). In contrast, upon knockout of linc-Brn1b, we observed a significant increase in expression of linc-Brn1a (p<0.01; Cuffdiff2), which shares a bidirectional promoter with Brn1 ( Figure 6A ). This suggests opposing regulatory effects on the neighboring lincRNA and protein coding genes upon deletion of linc-Brn1b.
Gene set enrichment analysis (GSEA) revealed a significant decrease in genes associated with cellular growth and proliferation in linc-Brn1b −/− relative to wild type at all three time points sampled and an increase in gene sets positively correlated with neuronal maturation ( Figure 6C ). These results are consistent with a predicted role for linc-Brn1b derived from our initial GBA analyses ( Figure 1C ) and suggest a function for linc-Brn1b in the differentiation of neural progenitors and neurogenesis in the telencephalon.
To investigate potential abnormalities of linc-Brn1b −/− mutants, we concentrated on the dorsal telencephalon (the developing cerebral cortex). First, to quantify the proliferation of cortical progenitors, we evaluated the expression of the mitotic marker phosphorylated histone H3 (pH3) in E15.5 wild type and linc-Brn1b −/− cortices ( Figure 6D ). Quantification of pH3 + cells revealed a significant and specific reduction in the relative percentage of pH3 + intermediate progenitor cells within the SVZ (36.88% decrease; p<3.93e-05; Student's t test) in linc-Brn1b mutant vs control cortices ( Figure 6E ). The observed abnormalities were specific to intermediate progenitors, as there was no statistically significant change in the proliferation rate of apical progenitors within the VZ ( Figure 6E) .
In agreement with a reduction in intermediate progenitors of the cortical SVZ we found decreased expression of the markers TBR2 ( Figure 6F ), Cux2 ( Figure 6G ), and Svet1 ( Figure 6H) (Tarabykin et al., 2001; Zimmer, 2004; Molyneaux et al., 2007; Arnold et al., 2008; Cubelos et al., 2008; Sessa et al., 2008) in linc-Brn1b −/− mutants. Together, the data indicate that linc-Brn1b knockout mice exhibit a decrease in proliferation of cortical progenitors in vivo, and that this defect is restricted to a specific subpopulation of progenitors in the SVZ of the developing cortex.
Cortical lamination is abnormal in linc-Brn1b
−/− mice To investigate whether the observed decrease in SVZ progenitors resulted in an overall reduction in cortical thickness, we measured linc-Brn1b −/− mutants and wild-type littermates at P7. The distance between the pia and the white matter was measured at matched medio-lateral and rostro-caudal locations (n = 17 wild-type sections and n = 10 linc-Brn1b −/− sections). We reproducibly observed a significant 6.24% decrease in the total thickness of the neocortex in the mutants, relative to wild type (1317.31 µm ± 20.03 in linc-Brn1b −/− vs 1404.90 µm ± 15.07 in wild type; p<0.002, Student's t test) (data not shown). To define whether generation of projection neuron subtypes was affected in the absence of lincBrn1b, cortices from linc-Brn1b −/− and wild-type littermates were collected at P7 and immunostained for markers of different projection neuron classes: CUX1, a marker of upper layer II/III and IV callosal Research article projection neurons (Zimmer, 2004) (Figure 7A ), CTIP2, a marker of layer V subcerebral projection neurons (Figure 7B) , and TLE4, a marker of layer VI corticothalamic projection neurons (Koop et al., 1996; Molyneaux et al., 2005) (Figure 7C) . Measurements of the thickness of each cortical layer showed a distinct reduction in the upper layer II/III-IV (11.62% reduction in absolute thickness in linc-Brn1b −/− vs wild type; Figure 7A , p<0.0004; Student's t test), which was also detectable by histological Nissl staining ( Figure 7D ). In contrast, no significant change in the absolute thickness of either layer V ( Figure 7B , p<0.18; Student's t test) or VI ( Figure 7C , p<0.54; Student's t test) was detected.
In order to determine whether the number of specific classes of neurons within layers was affected in the mutant cortex, we quantified the percentage of CUX1 + , CTIP2 + and TLE4 + neurons. In agreement with a reduction in the thickness of layer II/III-IV, we observed that the number of CUX1 + callosal −/− brains. *p<0.05, **p<0.01, ***p<0.001; Student's t test. Scale bars = 500 µm (A-E) and (G-H), 100 µm (F). ctx, cortex; cc, corpus callosum; str, striatum; PMBSF and ALBSF, posteriomedial and anteriolateral barrel subfield. DOI: 10.7554/eLife.01749.017
Disorganization of the barrel cortex in linc-Brn1b
−/− mice Whole mount analysis of linc−Brn1b areal distribution showed high levels of expression in primary somatosensory cortex, an area that in rodents receives thalamocortical afferents relaying sensory information from the mustacial vibrissae (Petersen, 2007) . Given the expression of linc-Brn1b within this region, and the requirement for proper specification of upper layer neurons, we investigated whether linc-Brn1b is required for the proper development of the somatosensory cortex and organization of the barrel structures. In situ hybridization against the barrel cortex marker RAR-related orphin beta (Rorβ) (Jabaudon et al., 2012) , on matched coronal sections of P7 wild type and knockout mouse cortices demonstrated a reduction in the total size of the barrel cortex in the linc-Brn1b −/− mice ( Figure 7E ) with a more pronounced loss of Rorβ + neurons at the medial edge. Histochemical staining of cytochrome oxidase C activity in the somatosensory cortex was examined and showed a distinct disruption of the individual barrel structures, particularly within the anteriolateral barrel subfield (ALBSF) ( Figure 7F) . A reduction in overall area and number of barrels in linc-Brn1b mutants was also observed in the highly organized posteriomedial barrel subfield (PMBSF). These findings, already consistent with the Rorß in situ hybridization data, were confirmed in P7 coronal sections immunostained with vGLUT2 ( Figure 7G ) and 5-HTT ( Figure 7H) , both of which specifically label the barrel structures. Analysis of both of these markers corroborates a specific impairment of the barrels within the ALBSF, and a general disorganization of individual barrel structures in the linc-Brn1b −/− mice. Taken together, these results demonstrate the requirement of linc−Brn1b for the proper development of different classes of projection neurons within the cerebral cortex, and suggest that the loss of linc−Brn1b may potentially have broader implications for state-dependent cortical sensory processing.
Discussion
In the post genomic era, thousands of long noncoding RNAs have been discovered as transcribed units in mammalian genomes. However, what fraction of these new transcripts have general functional significance in vivo is debated. While several studies have indicated a role for lincRNAs in diverse biological processes (Ponting et al., 2009; Rinn and Chang, 2012; Mercer and Mattick, 2013; Ulitsky and Bartel, 2013) , it has been suggested that most transcripts could represent nonfunctional transcriptional by-products (Struhl, 2007; Kowalczyk et al., 2012) . Early critical studies of knockout strains (e.g., Xist and Tsix) did find lncRNAs implicated in X inactivation to be required for life. Yet, of the relatively few lncRNA mouse models derived since, many have displayed subtle defects or no phenotype (Ripoche et al., 1997; Gordon et al., 2010; Anguera et al., 2011; Nakagawa et al., 2011; Zhang et al., 2012) .
Other strategies using RNAi and xenografts to assess the function of lncRNAs in vivo have revealed interesting roles in development and tumor growth (Ulitsky et al., 2011; Wang et al., 2011; Yang et al., 2013) . Together with difficulties in finding a phenotype in mouse models such as Malat1, Neat1 (Nakagawa et al., 2011; Zhang et al., 2012) , these findings have led some to suspect that acute inactivation of lncRNAs leads to stronger phenotypes than constitutive deletions, where compensatory events may occur. Therefore, our study, grounded in genetic deletions, demonstrates the important physiological insights that can be gleaned by constitutive lincRNA knockouts.
By leveraging our large-scale RNA-sequencing and genomics studies in combination with an integrated and multifaceted candidate selection pipeline, we were successful in finding physiologically essential lincRNAs. Through the initial characterization of the 18 lincRNAs knockout strains generated here, we found three that exhibit peri-or post-natal lethality and two additional ones with distinct developmental defects. Future studies will describe in detail other promising phenotypes.
A few recent studies have demonstrated that lincRNAs regulate neighboring protein coding genes and thereby may function as cis-enhancers or cis-regulatory elements (Ørom et al., 2010; Wang et al., 2011) . Here, we were able to examine several lincRNAs and the regulation of the neighboring protein coding genes in a genetically defined context. We find one instance where the deletion of a lincRNA, Fendrr, phenocopies the neighboring protein coding gene despite a non-significant effect on Foxf1 gene expression. Interestingly, chromatin predictions of enhancers (Shen et al., 2012) suggest this lincRNA may have enhancer-like properties (H3K4me1 and Pol II). However, our genetic analysis is not consistent with the notion of Fendrr as a chromatin signature-defined 'enhancer'. Specifically, Grote et al observed a similar lethality phenotype in Fendrr mutants, yet their strategy (insertion of a strong transcription stop sequence) retained almost the entire DNA segment of Fendrr. This suggests that Fendrr cannot be acting simply as a DNA enhancer, although we cannot rule out the passive act of transcription as being functional. In our model, both the endogenous promoter and first exon remain. Moreover, the introduced lacZ reporter is actively transcribed as well, thus ruling out the passive act of transcription for Fendrr activity. Finally, since this lincRNA does not appear to act as a local enhancer and does not encode a small peptide based on PhyloCSF and Ribosome profiling analyses, we believe Fendrr to be a physiologically relevant and functional RNA molecule.
Interestingly, Fendrr mutant mice exhibit many features of Foxf1a protein coding gene heterozygous mutants (Mahlapuu et al., 2001 ). Since we do not observe a significant decrease in Foxf1a expression in Fendrr mutants, this raises the possibility that Fendrr could act downstream of Foxf1a. The FOXF1A protein plays an important role in the development of the lung and the gastrointestinal tract (Mahlapuu et al., 2001) . Similarly, we found that Fendrr is expressed in the mesenchyme of these tissues and that homozygote mutant mice display lung and gastrointestinal tract defects most likely leading to perinatal lethality. Several cases of genetic deletions encompassing the neighboring protein coding gene FOXF1, and also FENDRR have been observed in neonates with the lethal lung disorder 'alveolar capillary dysplasia with misalignment of pulmonary veins' (ACD/MPV) (Szafranski et al., 2013) . This supports our hypothesis that lincRNAs can be required for normal organ development and misregulated in pathological states, which could translate to human disease.
Deletion of both Peril and Mdgt also results in viability defects. Mdgt is transcribed from a bidirectional promoter shared with Hoxd1, which is located only 84 bp away from Mdgt. Although we do not exclude that Hoxd1 expression could be affected by our Mdgt deletion strategy, the phenotype of homozygous Hoxd1 mutants, which are viable and fertile, is in sharp contrast with Mdgt −/− mutants (Guo et al., 2010) . Thus, deletion of Mdgt does not phenocopy Hoxd1, indicating a distinct function for this lincRNA. Interestingly, mice with a deletion of the adjacent Hoxd3 protein coding gene display reduced viability similar to Mdgt (Condie and Capecchi, 1993) . However, contrary to Mdgt −/− , the surviving Hoxd3 −/− mice do not appear to have a growth defect, again suggesting a distinct function for Mdgt.
Neither the Peril nor Mdgt locus appears to be enriched for the signature enhancer modifications H3K4me1, H3K27ac in any public mouse ENCODE datasets. In the case of Peril, no genes were found significantly differentially expressed in knockout vs wild-type brains within ±1 Mb of Peril (Figure 3-figure supplement 2C ; p<1.0, bootstrapped from 1000 random genomic intervals). Therefore, cis effects, as suggested by other enhancer-associated lincRNAs like Hottip (Wang et al., 2011) , are unlikely. Collectively, these results suggest that lethality of the three lincRNAs observed in this study are likely not due to cis or enhancer-like RNA regulatory effects.
In addition to viability phenotypes, we also describe several developmental abnormalities such as body size and cortical defects in the linc-Brn1b mutant strain. Based on currently available public data, the linc-Brn1b locus does not appear to have enrichment for chromatin marks characteristic of enhancers, but rather the canonical H3K4me3/H3K36me3 signature of active transcription in the brain. In this case, however, deletion of linc-Brn1b did affect the expression of the neighboring protein coding gene. linc-Brn1b resides near Brn1 (Pou3f3), a key transcription factor that shares redundant roles with the closely related paralog Brn2 (Pou3f2) in upper layer cortical development. Interestingly, deletion of linc-Brn1b results in a significant reduction in the neighboring BRN1 protein ( Figure 6 ). However, in contrast to linc-Brn1b mutants, deletion of Brn1 alone does not lead to defects in cortical lamination. Only when both Brn1 and Brn2 are deleted (Brn1/2 double mutants) is a reduction in layers II-IV neurons observed (McEvilly, 2002; Sugitani et al., 2002; Dominguez et al., 2012) . Despite the differential regulation of the adjacent Brn1 gene, linc-Brn1b does not appear to act as a general cis-enhancer. The region has five other genes within ±1 Mb that are differentially expressed. However, this is not significant given the dramatic changes to the transcriptome in the linc-Brn1b −/− E13.5 telencephalon (Figure 3-figure supplement 2B ; p<0.225, bootstrapped from 1000 random genomic intervals).
We do not observe a significant difference in expression of the paralogous Brn2 protein coding gene in any linc-Brn1b −/− developmental stage analyzed when compared to wild type ( Figure 6-figure supplement 1C) , Thus, despite an observed decrease in Brn1 expression in linc-Brn1b −/− , deletion of linc-Brn1b does not phenocopy deletion of the neighboring protein coding gene Brn1. In fact, ablation of linc-Brn1b results in a stronger phenotype than that observed for the neighboring protein coding gene, suggesting additional roles for this lincRNA. In addition, we observe expression of linc-Brn1b in regions of the brain with no known expression of Brn1. Together, these observations suggest that lincRNAs adjacent to important developmental regulators may act on upstream and/or distinct pathways in addition to already reported cis-enhancer-like mechanisms (Ørom et al., 2010; Wang et al., 2011) .
Further leveraging our genetically defined deletion we gleaned additional insights into lincRNA biology and transcriptional regulation in vivo. It has been noted that lincRNAs have a propensity to be transcribed from bidirectional promoters (Cabili et al., 2011; Pauli et al., 2012; Ulitsky and Bartel, 2013) . New studies have also suggested that many lincRNAs transcribed from bidirectional promoters are unstable and likely non-functional transcripts Sigova et al., 2013) . Interestingly, Fendrr is transcribed from a bidirectional promoter. Here, we observe that deletion of Fendrr is lethal despite leaving an intact promoter, expression of the first exon and not interfering with Pol II dynamics at this locus. Similarly, RNA-Seq analysis of linc-Brn1b knockout revealed a strong and significant upregulation of linc-Brn1a, a lincRNA transcribed from a bidirectional promoter shared with Brn1. This incongruous activity on adjacent genes (decrease in Brn1 protein coding gene and increase in linc-Brn1a transcribed from a bidirectional promoter with Brn1) observed in the linc-Brn1b −/− brain is suggestive of a functional role for the dynamically regulated linc-Brn1a, rather than transcriptional noise from bidirectional transcription from the protein coding gene promoter. Together, these findings confirm that not all lincRNAs transcribed from a bidirectional promoter are irrelevant transcriptional by-products, but rather suggests that some fraction of these transcripts play critical functional roles during development.
Our framework for lincRNA candidate selection for genetic analysis, based on RNA-sequencing catalogs and genomic studies, has led us to unexplored roles for lincRNAs in brain development. The brain (and the CNS more broadly) constitutes one of the most complex and fast evolving organs in the body. Here, it is likely that complex regulatory mechanisms of lincRNAs have evolved to build the layered control of gene expression necessary to generate the unparalleled cellular diversity and complex function of this organ. linc-Brn1b represents an example of a lincRNA that has an effect on development of the cerebral cortex. Beyond linc-Brn1b, many more lincRNAs from our screen have similar restricted patterns within progenitors in the VZ and SVZ of the telencephalon, possibly suggesting roles in neurogenesis. Others have highly cell-specific and dynamic in vivo expression patterns in distinct regions of the brain (Mercer et al., 2008) . Thus, it is likely that more extensive work will reveal additional lincRNA mutants strains with additional brain and/or behavioral defects yet unexplored here. While rigorous behavioral studies will, in the future, determine whether loss of a lincRNA may result in specific behavioral abnormalities, we have made promising initial observations on two mutant strains. One mutant strain (Spasm) has tremors and a propensity to develop spastic movements upon handling, while a second strain (linc-p21) displays clasping of hind limbs when lifted by the tail (Sauvageau et al., unpublished) .
As a whole, our 18 lincRNA knockout mouse models have revealed important aspects of lincRNA biology and constitute a useful resource for many future studies on the roles of lincRNAs in mammalian development, physiology and behavior.
Materials and methods
Mice lincRNA knockout mice were generated by replacing the selected lincRNA gene with a lacZ cassette. Briefly, targeting constructs were constructed using VelociGene technology as described previously (Valenzuela et al., 2003) . The VelociGene Allele Identification Numbers are shown in Supplementary file 1A. Linearized targeting constructs, generated by gap repair cloning containing mouse lincRNA upstream and downstream homology arms flanking a KOZAK-ATG-lacZ-pA-LoxP-hUb1-EM7-neo(superscript R)-pA-LoxP cassette, were electroporated into VGF1 hybrid mouse embryonic stem (ES) cells, derived from a 129S6S v/Ev female to a C57BL/6N male mating. Mouse ES cells carrying a heterozygous deletion of the lincRNA gene were identified by loss-of-function allele screening with 2 Taqman qPCR assays (Supplementary file 1F) . Simultaneous replacement of the lincRNA gene with the lacZ cassette was confirmed by gain-of-allele Taqman assays against the lacZ and neomycin resistance cassette (Supplementary file 1F) . Probes were labeled with 6-carboxy-fluorescein (FAM) on their 5′ ends and BHQ-1 on their 3′ ends. Targeted ES clones were introduced into an 8-cell stage mouse embryo using the VelociMouse method (Poueymirou et al., 2006) . Mice were backcrossed once with C57BL/6J. Mutant mice were identified by genotyping for loss of lincRNA allele and gain of lacZ cassette. Toe clips, embryos or yolk sac were digested for 30 min at 95°C in 100 μl of 25 mM Sodium Hydroxide and 0.2 mM EDTA. Tissue digestion was neutralized by adding 100 μl of 40 mM Tris-HCl. PCR reactions using 4 μl of digested tissue with 10 mM lacZ specific and lincRNA gene specific primer pairs (Supplementary file 1C for sequences) were then performed and run on a 2% agarose gel. PCR conditions were as follows: 5 min at 95°C followed by 35 cycles of 30 s at 95°C, 45 s at 60°C, 30 s at 72°C and a final step at 72°C for 2 min. Mice were housed under controlled pathogen-free conditions (Harvard University's Biological Research Infrastructure) and experiments were approved by the Harvard University Committee on the Use of Animals in Research and Teaching. Viability of the 18 lincRNA mutant strains was determined at postnatal day 21 by genotyping the progeny of heterozygous intercrosses (Supplementary file 1C for genotyping primer sequences) . In the case of lethal strains, the developmental stage at which lethality occurs was determined by genotyping of embryos at E14.5 and E18.5 and newborns. Respiratory function (Fendrr mutant strain) was evaluated in surgically delivered E18.5 embryos from heterozygous intercrosses (Eggan et al., 2001) . After cleaning of the airways, pups were placed on a 37°C warm pad and observed for sign of breathing.
RNA isolation and mRNA-Seq library preparation
Total RNA from embryonic and postnatal mouse tissues, neural stem cells, and neurospheres was isolated using TRIzol (Life Technology, Carlsbad, CA)/chloroform extraction followed by spin-column purification (RNeasy mini kit, Qiagen, Venlo, Netherlands) according to the manufacturer instructions. RNA concentration and purity were determined using a Nanodrop (Thermo Fisher, Waltham, MA). RNA integrity was assessed on a Bioanalyzer (Agilent, Santa Clara, CA) using the RNA 6000 RNA chip. High-quality RNA samples (RNA Integrity Number ≥8) were used for library preparation. mRNAseq libraries were constructed using the TruSeq RNA Sample Preparation Kit (Illumina, San Diego, CA) as previously described (Trapnell et al., 2012a; Sun et al., 2013) . 500 ng total RNA was used as input for the TruSeq libraries from mouse tissues, and 200 ng for the libraries from neural stem cells and neurospheres. Prior to sequencing, libraries were run on a Bioanalyzer DNA7500 chip to assess purity, fragment size, and concentration. Libraries free of adapter dimers and with a peak region area (220-500 bp) ≥80% of the total area were sequenced. Individually barcoded samples were pooled and sequenced on the Illumina HiSeq 2000 platform.
RNA-Seq analysis
Paired-end 101 bp reads were aligned to the mouse (mm9) reference genome assembly and, for the human neuronal differentiation time course also to the human (hg19) assembly, using Tophat2 (Trapnell et al., 2009 ) with default options and assembled into transcripts with Cufflinks (Trapnell et al., 2012a (Trapnell et al., , 2012b . Aligned reads and assembled transcriptome catalog were used as input for Cuffdiff2 (Trapnell et al., 2012a) to determine expression levels (FPKM, Fragments Per Kilobase per Million mapped reads) and differential expression between conditions using default options. CummeRbund v2.1 (http://compbio.mit.edu/cummeRbund/) was then used to process, index, and visualize the output of the Cuffdiff2 analyses. Gene set enrichment analysis (GSEA) and Guilt-by-Association analysis (GBA) were performed to predict the effect of gene expression changes on biological processes. Detailed description of GSEA and GBA analysis, RNA isolation, and libraries preparation are provided in the Extended Experimental Procedures. Cis-enhancer activity was tested by determining the number of genes with differential expression in a particular Knockout vs wild type contrast within ±1 Mb window of the targeted lincRNA. 1000 random genomic intervals of the same size were obtained and interrogated in kind to determine how often the same number of differentially expressed (DE) genes could be identified. The ratio of intervals with DE genes >= the number of DE genes in the target-flanking window to the number of iterations, provided a bootstrapped p value and false discovery rate estimate.
Gene set enrichment analysis (GSEA) and Guilt-by-Association (GBA) analysis GSEA was performed to predict the effect of the significant gene expression changes on biological processes in the knockout mice. For a given comparison of KO vs WT differential expression, all genes were rank-ordered by their Cuffdiff2 test-statistics and mouse gene identifiers were mapped to human HUGO gene names. Genesets from the Reactome collection at mSigDB were obtained and for each gene set, the relative enrichment or depletion within our ranked list was determined via Mann-Whitney U-test. p values were corrected for multiple tests using the Benjamini-Hochberg method. Genesets with q<0.001 were selected and presented as a heatmap with color mapped to the Z-score of the Cuffdiff2 test statics for genes in the specific gene set relative to all genes. Redundant genesets were aggregated into higher-level biological processes.
Predictive GBA analysis for 17/18 tested lincRNAs was conducted as follows: Pearson correlation values of FPKM expression profiles were calculated for each lincRNA to all protein coding genes across a compendium of RNA-Seq samples (combination of in-house samples and samples from [Merkin et al., 2012] ). Protein coding genes were then rank-ordered and subjected to the gene set enrichment analysis described above. Significant genesets for a given lincRNA represent the most likely pathways/biological processes for which this lincRNA may play a role.
lacZ expression and histology
Expression of the knocked-in lacZ reporter gene was assessed in heterozygous mice. Embryos (from E13.5 to E18.5) were fixed in 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS) overnight at 4°C prior to dissection of the brain, lung and respiratory tract, digestive tract, heart, and other organs. P7 brain, from linc-Brn1b mutant strain, were dissected from pups transcardially perfused with 4% paraformaldehyde (PFA), and fixed overnight at 4°C. The fixed tissues were rinsed three times at room temperature in PBS, 2 mM MgCl2, 0.01% deoxycholic acid, 0.02% NP-40. X-gal staining was performed by incubating the tissues for up to 16 hr at 37°C in the same buffer supplemented with 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide and 1 mg/ml X-gal. Staining reaction was stopped by washing three times in PBS at room temperature, followed by 2 hr post-fixation in 4% PFA at 4°C. Stained whole organs and sagittal brain sections were imaged using a Leica M216FA stereomicroscope (Leica Microsystems, Buffalo Grove, IL) equipped with a DFC300 FX digital imaging camera (Watson et al., 2008) . Histology was performed at the Rodent Histopathology Service of the Dana Farber/Harvard Cancer Center Pathology Research Core. Embryos were harvested, fixed in Bouin's solution and embebbed in paraffin. Microtome sections were stained with hematoxilin and/or eosin for histological analysis.
Nissl staining and immunocytochemistry
Embryonic brains, dissected in cold PBS and fixed in 4% PFA/PBS overnight at 4°C, and P7 brains dissected from pups transcardially perfused with 4% PFA and post-fixed as described above, were processed for Nissl staining and immunofluorescence as previously described (Englund et al., 2005; Molyneaux et al., 2005) . Nissl-stained and immunostained sections were imaged using a Nikon 90i fluorescence microscope equipped with a Retiga Exi camera (Q-IMAGING, Surrey, Canada) and acquired with Volocity image analysis software v4.0.1 (Perkin Elmer, Waltham, MA). For quantification of overall cortical thickness, cortical layers and number of CUX1+, CTIP2+ and TLE4+ cells within the primary somatosensory cortical area, anatomically matched sections were processed (n = 3 linc-Brn1b −/− ; n = 3 wild-type, at P7). Boxes of 300 pixels in width and spanning the thickness of the cortex were superimposed at matched locations on each section, and the overall cortical thickness was measured as the distance from the pia to the white matter in each box, using ImageJ. Specific layer thicknesses were measured at the midpoint of the matched-location 300 pixel images for each of the TLE4 + , CTIP2 + and SATB2 + immunofluorescence stainings using ImageJ. Layer VI thickness was measured as the distance between the dorsal edge of the TLE4 + region and the white matter. Layer V thickness was determined by the span of the CTIP2 + region, and layer II-IV thickness were measured as the SATB2 + region between the dorsal edge of the CTIP2 + stain and the pia. In each case results were expressed as mean ± SEM. Cell counts of the specific neuronal subpopulations were obtained using the ITCN plugin for ImageJ and results were expressed as mean ± SEM. A priori criteria were defined for analysis. Statistical analysis was performed using R unpaired Student's t test assuming equal variance was used for the pairwise comparisons.
Antibodies and image acquisition
Primary antibodies and dilutions were as follows: anti-ßgal (CGAL-45; 1:500; Immunology Consultants Laboratory, Portland OR), anti-SATB2 (ab51502; 1:50; Abcam, Cambridge, UK), anti-CUX1 (sc-13024; 1:100; Santa Cruz Biotechnology, Dallas, TX), anti-pH3 (06-570; 1:500; Millipore, Billerica, MA), anti-TBR2
(1:2000; Gift from Robert F Hevner Lab), anti-CTIP2 (ab18465; 1:100; Abcam), anti-TLE4 (sc-9125; 1:100; Santa Cruz), anti-vGLUT2 (MAB5504; 1:50; Millipore), anti-5-HTT (PC177L; 1:1000; Millipore), anti-TUJ1 (mms-435P; 1:1000; Covance, Princeton, NJ). Secondary antibodies were from the Molecular Probes (Eugene, OR) Alexa series and were used at 1:750 dilution. Immunostained sections were imaged using a Nikon 90i fluorescence microscope equipped with a Retiga Exi camera (Q-IMAGING) and acquired with Volocity image analysis software v4.0.1 (Improvision).
Cytochrome oxidase staining linc-Brn1b
−/− and wild-type littermates at P7 were anesthetized, perfused with 4% PFA, decapitated, and the brain rapidly removed. The brains were post-fixed in 4% PFA for 3 hr at 4°C. Cortices containing the barrel field were dissected and flattened as described (Welker and Woolsey, 1974) , post-fixed in 4% PFA for 12-14 hr at 4°C and sectioned by using a vibratome (80 μm). Sections were incubated in phosphate buffer containing 0.5 mg/ml DAB, 0.18 mg cytochrome C, and 40 mg/ml sucrose for 3-5 hr at 37°C, rinsed, and mounted in Fluoromount-G (SouthernBiotech, Birmingham, AL) (Wong-Riley, 1979; Land and Simons, 1985) .
In situ hybridization
Nonradioactive in situ hybridization was performed on 40 μm vibratome sections mounted on superfrost slides (Fisher Scientific, Waltham, MA) as previously described (Berger and Hediger, 2001; Arlotta et al., 2005) . The probe for Svet1 was a gift from M Studer. Probes for RorB (nt 1573-2087 of NM_146095) and Cux2 (nt 1069-11694 of NM_007804) transcripts were generated by PCR from mouse brain cDNA and subcloned in pCRII-TOPO (Life Technologies, Carlsbad, CA). Antisense riboprobes were generated by in vitro transcription using SP6 or T7 polymerase (Roche Applied Science, Penzberg, Germany) as previously described. Sense probes were used as negative controls.
Single molecule FISH
Single molecule FISH was performedas described by Raj et al. (2008) . Briefly, oligonucleotide probes targeting and tiling Peril (48 probes) and linc-Brn1b (20 probes) were conjugated to Quasar 570 fluorophores and HPLC purified (Biosearch Technologies, Petaluma, CA). A list of the Peril and linc-Brn1b probes (sequence, position, and %CG content) is provided in Supplementary file 1E. Dissociated E14.5 cortical neurospheres or mouse ES cells were fixed in 2% formaldehyde for 10 min, washed twice with PBS, and permeabilized with 70% ethanol. The cells were then seeded onto previously gelatinized two-chamber cover glasses. Prior to hybridization, the cells were rehydrated in wash buffer containing 10% formamide and 2 × SSC for 5 min. Probes (0.5 ng/μl final concentration) were hybridized in 10% dextran sulfate, 10% formamide, and 2 × SSC at 37°C overnight. After hybridization, cells were washed twice with wash buffer at 37°C for 30 min (with DAPI added to the second wash for nuclear staining), and twice with 2 × SSC. After the SSC wash, the cells were equilibrated in anti-fade buffer (2 × SSC, 0.4% glucose, 10 mM Tris pH 8.0) for 3-5 min. Cells were mounted in 100 μl anti-fade buffer supplemented with 1 μl of glucose oxidase (G2133-10KU; Sigma-Aldrich, St. Louis, MO) and 1 μl of catalase (C3515-10 MG; Sigma-Aldrich) and immediately imaged with a LSM 700 Inverted Confocal microscope (Zeiss, Jena, Germany). 25 Z-stacks were taken per field, using DAPI and laser 639 for excitation.
Human neural stem cell culture and differentiation H1 human neural stem cells were prepared as described previously (Arnold et al., 2008; Goff et al., 2009 ) and grown at 37°C, 5% CO 2 on 1:4 diluted Matrigel-coated wells in neural proliferation medium (NPM; 50% DMEM/F12 Glutamax, 50% Neurobasal medium, 0.5X N2, 0.5X B27 without vitamin A, 20 ng/ml FGF [Life Technologies]). For differentiation, cells were plated at a density of 10 6 cells per well in a 6-well plate and allowed to proliferate for one day in the NPM medium. Neural induction was then initiated by withdrawal of FGF and addition of BDNF by switching the medium to neural differentiation medium (NDM; 100% Neurobasal medium, 1X B27 without vitamin A [Life Technologies], 10 ng/ml BDNF [Peprotech, Rocky Hill, NJ] .) Differentiating cultures were maintained by refreshing NDM every other day until collection. Samples of these cultures were collected at days 0, 1, 2, and 4. Remaining cells (those designated for collection at days 5, 11, and 18) were replated at day 4 at a density 10 6 cells per well of a Poly-D-lysine/laminin-coated 6-well plate. Cells were harvested with Accutase (Stem Cell Technologies, Vancouver, Canada) and RNA collected as described above.
Western blot linc-Brn1b
−/− and WT E14.5-derived neurospheres (passage 3) and E15.5 cortices were lysed in RIPA buffer (1% NP-40, 1% Na-deoxycholate, 0.2% SDS, 50 mM Tris 7.4, 500 mM NaCl) containing protease inhibitor cocktail (Roche Applied Science). Proteins were resolved by SDS-PAGE and electroblotted. Blots were probed sequentially for BRN1 (anti-BRN1, sc-6028-R, Santa Cruz) and GAPDH (anti-GAPDH, sc-365062-R, Santa Cruz) to control for protein loading. Immunoreactive bands were detected by enhanced chemiluminescence (SuperSignal, Thermo Fisher Scientific, Waltham, MA) , and visualized with a Gel Doc (Biorad).
Accession numbers
All primary RNA-Seq data are available at the Gene Expression Omnibus (GSE49581).
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